Key facts
- This page summarizes Alison B. Fleming's Form 4 filing for COLLEGIUM PHARMACEUTICAL, INC (COLL).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 12 Aug 2021, 16:03.
Alison B. Fleming - 10 Aug 2021 Form 4 Insider Report for COLLEGIUM PHARMACEUTICAL, INC (COLL)
- Reporting relationship
- EVP & Chief Technical Officer
- Issuer ticker
- COLL
- Reported as of
- 10 Aug 2021
- Net transaction value
- -$26,376
- Reporting owner signature
- /s/ Colleen Tupper as Attorney-In-Fact For Alison B. Fleming
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Alison B. Fleming filed Form 4 for COLLEGIUM PHARMACEUTICAL, INC (COLL) on 12 Aug 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: -$26,376.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
COLL
transaction
Common Stock
Tax liability
- Transaction value
- $26,376
- Shares
- -1,386
- Change %
- -0.96%
- Price
- $19.03
- Shares after
- 143,694
- Date
- 10 Aug 2021
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.